Leo International Precision Health AG annual ebitda
2021
2022
2023
2024
Leo International Precision Health AG EBITDA Growth & History (LEOW)
Leo International Precision Health AG's calculated EBITDA was −€149,158.06 for fiscal 2024.
View full Leo International Precision Health AG company overviewLeo International Precision Health AG annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | −€149,158.06 | −€26,963.84 | — |
| 2023 | 2023-12-31 | −€122,194.22 | −€51,766.21 | — |
| 2022 | 2022-12-31 | −€70,428.01 | −€23,054.22 | — |
| 2021 | 2021-12-31 | −€47,373.79 | — | — |
Leo International Precision Health AG ebitda trends
Between the periods ended 2021-12-31 and 2024-12-31, Leo International Precision Health AG's ebitda decreased from −€47,373.79 to −€149,158.06, a change of −€101,784.27.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Leo International Precision Health AG source filings ↗